PRU perseus mining limited

0.15%

$6.72

UBS, page-8

First 8 Last

Share
Profile

Follow
kapten

40 Posts.

15

05/04/18

12:37

Post #: 32240710
Share

Originally posted by Samboy69 ↑

hillarious,
UBS was calling 30c now suddenly 55c AFTER it bought a net 3.5M shares last month at 42.5c.
They will flip this to you retailers at 10-25% profit, thats their plan imho.

When the stock was going up they were calling it lower then they quietly bought up averaging 42.5c while trading most of it at 1c margins according to the broker data posted by 8horse at -

32077372

INSTOs are trading this stock and trying to make easy margins if they can but the problem is that many INSTOs like Citigroup/Cannacord/Bellpotter are profit taking and selling in large volumes at these annual highs. Its INSTOs trading with INSTOs and now UBS has joined the game late while smart Cannacord called 70c targets was net selling at 43c! to UBS and CITIC!
hahaha

Expand

If you know the game so well, shouldn't you be playing it to your benefit. Instead of leaving all those easy margins go wasted.

PRU Price at posting: 47.3¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

SEN

Senetas experiences stronger cash flow as revenue rises, flags FY27 sales pipeline

4DX

4DMedical posts FY26 revenue growth as commercial deployment ramps up

D3E

D3 Energy detects gas in South African helium hunt well

CVL

Civmec earnings: Profit climbs as $1.4b order book backs FY27 growth

HotCopper Highlights Week 35: X2M, AnteoTech and Brighstar dominate forum chatter

IMR

Imricor Med and Philips launch commercial iMR lab solution

AS2

Capital Compass: Askari Metals advances Ethiopia strategy as permitting remains key focus

TGN

Tungsten has soared +700% YTD, the US is curbing its exports, and this ASX stock is targeting production in Q1CY27

NVA

Nova Minerals achieves key milestone on path to Alaskan antimony production

MEM

Memphasys receives early Thai FDA Felix approval

First 8 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.


Last $6.72		Change -0.010(0.15%)		Mkt cap ! $8.931B

Open	High	Low	Volume
$6.69	$6.79	$6.64	3.275M

Buyers (Bids)

Vol.	Price($)
71	$6.70

Sellers (Offers)

Price($)	Vol.
$6.80	45800

Last trade - 16.26pm 28/08/2026 (20 minute delay)

PRU (ASX) Chart

UBS, page-8

Senetas experiences stronger cash flow as revenue rises, flags FY27 sales pipeline

4DMedical posts FY26 revenue growth as commercial deployment ramps up

D3 Energy detects gas in South African helium hunt well

Civmec earnings: Profit climbs as $1.4b order book backs FY27 growth

HotCopper Highlights Week 35: X2M, AnteoTech and Brighstar dominate forum chatter

Imricor Med and Philips launch commercial iMR lab solution

Capital Compass: Askari Metals advances Ethiopia strategy as permitting remains key focus

Tungsten has soared +700% YTD, the US is curbing its exports, and this ASX stock is targeting production in Q1CY27

Nova Minerals achieves key milestone on path to Alaskan antimony production

Memphasys receives early Thai FDA Felix approval

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

UBS, page-8

Top Stories

Senetas experiences stronger cash flow as revenue rises, flags FY27 sales pipeline

4DMedical posts FY26 revenue growth as commercial deployment ramps up

D3 Energy detects gas in South African helium hunt well

Civmec earnings: Profit climbs as $1.4b order book backs FY27 growth

HotCopper Highlights Week 35: X2M, AnteoTech and Brighstar dominate forum chatter

Imricor Med and Philips launch commercial iMR lab solution

Capital Compass: Askari Metals advances Ethiopia strategy as permitting remains key focus

Tungsten has soared +700% YTD, the US is curbing its exports, and this ASX stock is targeting production in Q1CY27

Nova Minerals achieves key milestone on path to Alaskan antimony production

Memphasys receives early Thai FDA Felix approval

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News